Cleared Traditional

K101361 - REEFLEX PTA CATHETER

K101361 is an FDA 510(k) clearance for REEFLEX PTA CATHETER, manufactured by ClearStream Technologies , Ltd.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 82-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
82d
Days
Class 2
Risk

K101361 is an FDA 510(k) clearance for the REEFLEX PTA CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by ClearStream Technologies , Ltd. (Enniscorthy, County Wexford, IE). The FDA issued a Cleared decision on August 4, 2010 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all ClearStream Technologies , Ltd. devices

FDA 510(k) Submission Details - K101361

510(k) Number K101361 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 14, 2010
Decision Date August 04, 2010
Days to Decision 82 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 125d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 283
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K101361.
PACIFIC XTREME PTCA BALLOON DILATATION CATHETER
K103464 · Medtronic, Inc. · Dec 2010
ARMADA 14 PTA CATHETER
K102705 · Abbott Vascular, Inc. · Dec 2010
EVERCROSS 0.035 OTW PTA DILATION CATHETER
K103322 · Ev3, Inc. · Dec 2010
ULTRAVERSE 014 AND 018 BALLOON DILATATION CATHETERS
K093965 · C.R. Bard, Inc. · Mar 2010
PICA CATHETER
K093970 · Penumbra, Inc. · Jan 2010
STERLING ES MONORAIL AND OVER-THE-WIRE PTA BALLOON DILATATION CATHETERS MODEL H74939334XXXXXXX
K093636 · Boston Scientific Corp · Dec 2009